Sustained community transmission from multiple large outbreaks, fueled by declining MMR vaccination coverage in key communities, drives elevated trader expectations for a record 2026 U.S. measles total. As of September 10, CDC data show 3,294 confirmed cases—already exceeding the full-year 2025 count of 2,289—with 95% outbreak-associated, 94% among unvaccinated or unknown-status individuals, and 8% hospitalized across 47 jurisdictions. Pennsylvania now leads with rapid growth, followed by South Carolina and Utah, while official counts remain preliminary and subject to revision. Weekly CDC surveillance updates, wastewater monitoring, and the November Pan American Health Organization review of elimination status represent key near-term data points that could shift market-implied odds as new case reports and vaccination trends emerge.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้วผู้ป่วยโรคหัดในสหรัฐอเมริกาในปี 2026?
ผู้ป่วยโรคหัดในสหรัฐอเมริกาในปี 2026?
$7,897,763 ปริมาณ
$7,897,763 ปริมาณ
Dec 31, 2026
↑3.5k
99%
↑4k
96%
↑4.5k
86%
↑4.75k
86%
↑5k
70%
↑7.5k
15%
↑10k
7%
↑12.5k
2%
$7,897,763 ปริมาณ
$7,897,763 ปริมาณ
Dec 31, 2026
↑3.5k
$15,573 ปริมาณ
99%
↑4k
$241,109 ปริมาณ
96%
↑4.5k
$2,930 ปริมาณ
86%
↑4.75k
$626 ปริมาณ
86%
↑5k
$242,023 ปริมาณ
70%
↑7.5k
$194,220 ปริมาณ
15%
↑10k
$6,524,884 ปริมาณ
7%
↑12.5k
$356,740 ปริมาณ
2%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Sustained community transmission from multiple large outbreaks, fueled by declining MMR vaccination coverage in key communities, drives elevated trader expectations for a record 2026 U.S. measles total. As of September 10, CDC data show 3,294 confirmed cases—already exceeding the full-year 2025 count of 2,289—with 95% outbreak-associated, 94% among unvaccinated or unknown-status individuals, and 8% hospitalized across 47 jurisdictions. Pennsylvania now leads with rapid growth, followed by South Carolina and Utah, while official counts remain preliminary and subject to revision. Weekly CDC surveillance updates, wastewater monitoring, and the November Pan American Health Organization review of elimination status represent key near-term data points that could shift market-implied odds as new case reports and vaccination trends emerge.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
ตลาดเปิดเมื่อ: Jun 30, 2026, 2:17 PM ET
ปริมาณการซื้อขาย
$7,897,763วันสิ้นสุด
Jan 1, 2027ตลาดเปิดเมื่อ
Jun 30, 2026, 2:17 PM ETผู้ตัดสินผล
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Sustained community transmission from multiple large outbreaks, fueled by declining MMR vaccination coverage in key communities, drives elevated trader expectations for a record 2026 U.S. measles total. As of September 10, CDC data show 3,294 confirmed cases—already exceeding the full-year 2025 count of 2,289—with 95% outbreak-associated, 94% among unvaccinated or unknown-status individuals, and 8% hospitalized across 47 jurisdictions. Pennsylvania now leads with rapid growth, followed by South Carolina and Utah, while official counts remain preliminary and subject to revision. Weekly CDC surveillance updates, wastewater monitoring, and the November Pan American Health Organization review of elimination status represent key near-term data points that could shift market-implied odds as new case reports and vaccination trends emerge.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
ปริมาณการซื้อขาย
$7,897,763วันสิ้นสุด
Jan 1, 2027ตลาดเปิดเมื่อ
Jun 30, 2026, 2:17 PM ETผู้ตัดสินผล
0x65070BE91...Sustained community transmission from multiple large outbreaks, fueled by declining MMR vaccination coverage in key communities, drives elevated trader expectations for a record 2026 U.S. measles total. As of September 10, CDC data show 3,294 confirmed cases—already exceeding the full-year 2025 count of 2,289—with 95% outbreak-associated, 94% among unvaccinated or unknown-status individuals, and 8% hospitalized across 47 jurisdictions. Pennsylvania now leads with rapid growth, followed by South Carolina and Utah, while official counts remain preliminary and subject to revision. Weekly CDC surveillance updates, wastewater monitoring, and the November Pan American Health Organization review of elimination status represent key near-term data points that could shift market-implied odds as new case reports and vaccination trends emerge.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว
ระวังลิงก์ภายนอก
ระวังลิงก์ภายนอก
คำถามที่พบบ่อย